Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. - Wikidata - wikimedia - TriplyDB

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

http://www.wikidata.org/entity/Q54434638

about

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas Rhabdomyosarcoma: Advances in Molecular and Cellular Biology Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas A comparative review of canine and human rhabdomyosarcoma with emphasis on classification and pathogenesis Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives Recent advances in understanding and managing rhabdomyosarcoma Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma Alveolar rhabdomyosarcoma of nasopharynx and paranasal sinuses with metastasis to breast in a middle-aged woman: a case report and literature review Advances in sarcoma diagnostics and treatment Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo.Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.What is new in the biology and treatment of pediatric rhabdomyosarcoma?MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma.Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma Rhabdomyosarcoma: current challenges and their implications for developing therapies.Notch signaling in pediatric soft tissue sarcomas A novel algorithm for simplification of complex gene classifiers in cancer.Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.Rhabdomyosarcoma of the head and neck in children MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.Childhood rhabdomyosarcoma: recent advances and prospective views.Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.

P2860

Q26782842-7A711A25-0443-44D8-98A1-9FCC9DEB9818 Q26784207-169FF836-D931-44A5-8044-03C3EB6B560E Q26825000-0946A4B6-8AD7-4DF9-9B83-E02F7C5D32D7 Q26852801-127EEEC2-C1DE-43BE-B455-764F813487D2 Q26999187-B4B5B33A-C509-4DA7-9B79-E19B49D22EFB Q27024496-F273612E-09F5-443C-88B5-8AEF566E8418 Q27317150-5CAFBBAC-E3B9-44D6-94A7-9DBA2520F5FE Q28067923-A5C5B573-2ED0-4FA7-B516-B6D8AA0D5C11 Q28069695-2CD9A56D-C2C2-40B4-94FC-6FE533CD3F94 Q28537996-9BEFF40A-389C-429E-BACD-987B859EBFDA Q28741842-BF897E9D-EE9A-4047-B232-7B0A40A4C241 Q28830095-BDA28449-6A41-42F8-A7B4-4F008CE83FDE Q29028729-223932DD-0CA6-4778-BE79-163EF8A6103D Q30427044-10797865-DCD0-48FD-8A75-AA8459E5E346 Q33559468-07CFE5DF-9A6F-4636-8880-610AA80F3B29 Q33567593-BEF7F600-E510-40F9-BDF5-CEA533D52F54 Q33567866-95A35912-5F9A-479D-8101-828954115261 Q33756595-94F074FE-CC5E-4E99-A335-9F67A97899D6 Q33800135-CA73BF5B-B9AA-4BDA-8FF4-F16851026E12 Q33895506-A3A3D91D-90E9-4918-A591-ABA430E3B8C4 Q33906031-1321F941-10B6-43A3-AE4B-17E19B85BA3F Q33910609-A75808CC-87F0-4087-B873-B3E27D2B0235 Q33916861-3624E4D9-ADD3-4FBF-A945-D33F57ABE3A4 Q34191937-144B24CD-0313-4EB8-B365-69BC2E5629D1 Q34255856-AE1D055C-0AE9-4573-B28A-9FB2938EBC72 Q34400242-A9C81D31-4D41-4DD3-A694-1A4EE5C30731 Q34480012-04A0F584-CE33-4D92-9DE5-F453B17533F3 Q34520679-A69FEDFC-9676-4B44-9995-2C71B3D8ADE4 Q34580128-24EC98D3-83F1-4AC6-961F-F53728DB944B Q34700668-11D249AE-8B5A-47B6-A1F0-5C095A93D95B Q35602170-2292CC12-9438-475A-BF56-9F7DB4346882 Q35648994-C77DF698-23D5-48A9-9A54-9B0044A0D9B0 Q35667137-3EF07B1B-787D-4008-AE33-AAEDFD01BEF7 Q35689673-C93B0974-9BDD-46C4-8A88-52C9068B401E Q35711420-212DC9BB-DBE4-4D59-9424-8E876CB4C292 Q35847829-24F40895-6832-4568-8FAB-325B9D62B928 Q35861006-3706712D-A566-4F6C-A379-CC5798A21BD3 Q35922940-B7BF18CA-1A01-404A-83FF-F4586573100F Q35987311-021CF66E-9ADA-431E-88F8-0678B79CD278 Q36084235-620C10E0-508C-460F-A8A8-8C6911BB0410

P2860

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

http://www.wikidata.org/entity/Q54434638

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Fusion gene-negative alveolar ...... om embryonal rhabdomyosarcoma.

@en

Fusion gene-negative alveolar ...... om embryonal rhabdomyosarcoma.

@nl

type

label

Fusion gene-negative alveolar ...... om embryonal rhabdomyosarcoma.

@en

Fusion gene-negative alveolar ...... om embryonal rhabdomyosarcoma.

@nl

prefLabel

Fusion gene-negative alveolar ...... om embryonal rhabdomyosarcoma.

@en

Fusion gene-negative alveolar ...... om embryonal rhabdomyosarcoma.

@nl

P1433

Q54434638-A6F59771-AAA0-4DE2-A267-8B0261882A04

P1476

Q54434638-F2960425-A4E1-43E4-A284-761B7E8CA68D

P2093

Q54434638-04DB8371-FEED-46C0-8958-68B44108A346

Q54434638-1E7917BA-7E87-44E5-B33B-EAB2EA7E41E8

Q54434638-23A73839-2360-4347-A288-CFE06B1882F6

Q54434638-51A96DEC-E1FE-4E57-AFD5-44B86BF0BB04

Q54434638-6904016A-358E-4C72-A7A0-4793FE5252AC

Q54434638-6CDC252B-51EA-4D1B-8AD1-77D86A21B8E8

Q54434638-705135D5-6D58-492F-95D1-B4429E2562A2

Q54434638-7A851EC5-BAFF-4333-9962-15706B545BE4

Q54434638-8130B4AE-2EA6-41B7-A21D-B8A9986514FE

Q54434638-8522FE10-9CE9-46C5-80C3-FD33D032F4AA

P304

Q54434638-2B19B082-6B06-42EC-8F11-984F49D3353C

P31

Q54434638-86398B6D-F826-4B91-BD24-7192CFD12C5F

Q54434638-d66a4f6b-c4d2-47b2-90bf-08e6d2f86dcb

P356

Q54434638-53E12DA1-C1F2-4032-9EF1-CEF056D0A749

P407

Q54434638-47B154A1-EA89-4E3D-B037-AEACD8C34595

P433

Q54434638-DDF50631-B764-44AB-A022-CBE8C36AA7BD

P478

Q54434638-0D5B2DAF-4405-4EE5-9C38-DA67FDC0F829

P50

Q54434638-5DEE25CE-4D98-46F4-AFA4-587FEA4E72E5

Q54434638-5E904F30-D930-4336-AB6F-43770C7F0348

Q54434638-B8A659E9-8D87-44C2-9762-E40AF40B7C81

Q54434638-BB4855D2-1E8E-4EF1-A5AF-36FB878105DC

P577

Q54434638-E88C465A-BC36-4E20-BFE7-547B5C82A32F

P698

Q54434638-6690570A-73C4-4415-85CE-741458CCBA82

P356

JCO.2009.26.3814

P1433

Journal of Clinical Oncology

P1476

Fusion gene-negative alveolar ...... rom embryonal rhabdomyosarcoma

@en

P2093

Aurélien de Reyniès

http://www.w3.org/2001/XMLSchema#string

Benedicte Thuille

http://www.w3.org/2001/XMLSchema#string

Daniel Orbach

http://www.w3.org/2001/XMLSchema#string

Daniel Williamson

http://www.w3.org/2001/XMLSchema#string

Gaëlle Pierron

http://www.w3.org/2001/XMLSchema#string

Gilles Palenzuela

http://www.w3.org/2001/XMLSchema#string

Khin Thway

http://www.w3.org/2001/XMLSchema#string

Marick Laé

http://www.w3.org/2001/XMLSchema#string

Odile Oberlin

http://www.w3.org/2001/XMLSchema#string

Paul Fréneaux

http://www.w3.org/2001/XMLSchema#string

P304

2151-2158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.26.3814

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Edoardo Missiaglia

Kathryn Pritchard-Jones

Olivier Delattre

P577

2010-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20351326

http://www.w3.org/2001/XMLSchema#string